Delivery Order SPE2DB20D9331-SPE2DB25FL1X9
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,207.70 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg contraceptive systems. DMS Pharmaceutical Group, a woman-owned small business based in Park Ridge, Illinois, will perform the work at its primary location. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of October 3, 2025, and was awarded on September 12, 2025. No set-aside designation was applied to this...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $3,124.68 to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, with an ultimate completion date of September 15, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order falls under the company's larger Indefinite Delivery Contract with DLA valued at approximately $500 million...
- The Defense Logistics Agency awarded a $26,038.50 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mirena 52 mg contraceptive systems. The delivery order, issued on July 21, 2025, with an ultimate completion date of August 11, 2025, carries no set-aside designation. This award is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order valued at $3,124.68 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems, effective September 11, 2025, with an ultimate completion date of October 2, 2025. This delivery order is issued under a firm fixed-price contract structure with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, serves as the prime contractor and will...
- The Defense Logistics Agency awarded a $15,623.10 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mirena 52 mg contraceptive systems. This delivery order, issued on August 27, 2025, with an ultimate completion date of September 18, 2025, represents a discrete procurement action without set-aside designation. The award leverages DMS Pharmaceutical Group's established...
- The Defense Logistics Agency awarded a delivery order valued at $15,623.10 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mirena 52 mg systems. This firm fixed-price delivery order, issued on July 18, 2025, with an ultimate completion date of August 8, 2025, represents a continuation of DMS Pharmaceutical Group's substantial role as a pharmaceutical supplier to the Department of Defense. The award...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract, valued at $3,552.00, to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Mirena 52 mg contraceptive systems to support the medical supply needs of the Department of Defense (DoD) and Department of Veterans Affairs (VA). This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that...
- The Defense Logistics Agency awarded a delivery order valued at $5,207.70 to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, with an ultimate completion date of October 3, 2025. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected through firm fixed-price contracting without a set-aside designation. The delivery order falls under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA...
- The Defense Logistics Agency awarded a delivery order valued at approximately $26,039 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg contraceptive systems. This firm fixed-price delivery order, issued on August 3, 2025, with an ultimate completion date of August 22, 2025, is part of DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with DLA under the SPE2DB program, valued at $500 million through November 2026. The delivery order carries no set-aside...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $2,603.85 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order is set for ultimate completion by August 12, 2025, and represents a discrete purchase under the company's existing relationship with the DLA. This...
- SPE2DB20D9331Indefinite Delivery Contract
- SPE2DB20D9331-SPE2DB25FL1X9Delivery Order
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $3,645.39 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg contraceptive systems. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order is scheduled for ultimate completion on September 29, 2025, and represents a continuation of the company's ongoing pharmaceutical supply relationship with the federal government. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at approximately $500 million through November 2026. The IDC, part of the SPE2DB program, enables the agency to procure a comprehensive range of pharmaceutical products to support medical supply needs across Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain, with a portfolio encompassing prescription medications, biologics, vaccines, and specialty medical consumables distributed to military health facilities nationwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 9/8/25 |